Table 1. Main Features of 25 Patients... | American Society of Hematology

Table 1.

Main Features of 25 Patients With Mixed Cryoglobulinemia (MC)

Case	Age, Sex	HLA B8/DR3	Cryo Type	Liver Involvement^-150	Peripheral Neuropathy	Lymphoma	Kidney Involvement	Sicca Syndrome
1	62F	–	III	+	+	nd	–	–
2	68F	–	II	+	+	nd	–	–
3	65F	–	III	+	+	nd	–	–
4	61F	–	III	+	–	nd	–	–
5	64F	B8	II	–	+	+	+	–
6	60F	–	II	+	–	+	–	–
7	49F	–	II	+	–	+	–	–
8	67F	B8-DR3	III	+	–	nd	–	–
9	43F	B8-DR3	II	+	–	nd	–	–
10	55M	–	II	+	–	+	–	–
11	54M	DR3	III	+	–	+	–	–
12	63F	B8	II	+	–	+	+	–
13	58F	–	III	+	–	nd	–	+
14	75F	–	III	+	+	nd	–	–
15	52F	B8-DR3	II	–	+	+	–	–
16	70F	B8-DR3	III	–	+	+	–	+
17	63F	–	III	+	+	nd	–	–
18	50F	DR3	II	+	+	nd	–	–
19	57M	–	III	+	+	nd	–	–
20	70F	B8-DR3	II	+	+	nd	–	–
21	50F	B8-DR3	III	–	+	nd	–	–
22	54F	–	II	+	+	nd	–	–
23	44F	–	II	+	+	+	–	+
24	72F	B8-DR3	II	+	+	nd	+	–
25	44F	B8-DR3	II	+	–	nd	–	–

Case	Age, Sex	HLA B8/DR3	Cryo Type	Liver Involvement^-150	Peripheral Neuropathy	Lymphoma	Kidney Involvement	Sicca Syndrome
1	62F	–	III	+	+	nd	–	–
2	68F	–	II	+	+	nd	–	–
3	65F	–	III	+	+	nd	–	–
4	61F	–	III	+	–	nd	–	–
5	64F	B8	II	–	+	+	+	–
6	60F	–	II	+	–	+	–	–
7	49F	–	II	+	–	+	–	–
8	67F	B8-DR3	III	+	–	nd	–	–
9	43F	B8-DR3	II	+	–	nd	–	–
10	55M	–	II	+	–	+	–	–
11	54M	DR3	III	+	–	+	–	–
12	63F	B8	II	+	–	+	+	–
13	58F	–	III	+	–	nd	–	+
14	75F	–	III	+	+	nd	–	–
15	52F	B8-DR3	II	–	+	+	–	–
16	70F	B8-DR3	III	–	+	+	–	+
17	63F	–	III	+	+	nd	–	–
18	50F	DR3	II	+	+	nd	–	–
19	57M	–	III	+	+	nd	–	–
20	70F	B8-DR3	II	+	+	nd	–	–
21	50F	B8-DR3	III	–	+	nd	–	–
22	54F	–	II	+	+	nd	–	–
23	44F	–	II	+	+	+	–	+
24	72F	B8-DR3	II	+	+	nd	+	–
25	44F	B8-DR3	II	+	–	nd	–	–

Abbreviation: nd, not done.

Cirrhosis in 6 (no. 2, 14, 17, 22, 24, 25); chronic hepatitis in 11, abnormal ALT without biopsy in 4 (no. 4, 6, 10, 20).